TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 1, 2010, Pages 182-195

  Filipiak, Wojciech ^a,c   Sponring, Andreas ^a,c   Filipiak, Anna ^a,c   Ager, Clemens ^a,c   Schubert, Jochen ^c,d   Miekisch, Wolfram ^c,d   Amann, Anton ^a,c   Troppmair, Jakob ^a,b  

^a Universitatsklinik fur Chirurgie Innsbruck   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYLCROLEIN; 2 METHYL 1 PENTENE; 2 METHYL 2 BUTENAL; 2 PENTANONE; 2,4 DIMETHYL 1 HEPTENE; ACETONE; ALCOHOL; ALDEHYDE DERIVATIVE; CROTONALDEHYDE; ETHYL TERT BUTYL ETHER; ISOBUTYRALDEHYDE; ISOVALERALDEHYDE; METHACROLEIN; N BUTYL ACETATE; OCTANE; PYRROLE; SORBENT; TERT BUTYL METHYL ETHER; TUMOR MARKER; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

ADSORPTION; ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CANCER DIAGNOSIS; CASE REPORT; CELL STRAIN A549; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; DESORPTION; EARLY DIAGNOSIS; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MALE; MASS FRAGMENTOGRAPHY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THERMAL DESORPTION;

GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LUNG NEOPLASMS; VOLATILE ORGANIC COMPOUNDS;

EID: 74549129981     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0162     Document Type: Article

References (39)

1. Amann A, Smith D, editors. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. Singapore: World Scientific; 2005.
2. Amann A, Spanel P, Smith D. Breath analysis: the approach towards clinical applications. Mini Rev Med Chem 2007;7:115-29.
3. Risby T. Current status of clinical breath analysis. In: Amann A, Smith D, editors. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. Singapore: World Scientific; 2005, p. 251-65.
4. Chen CP, Chen CY, Lu CL, et al. Infrared spectrometry based 13C-octanoic acid breath test in measuring human solid gastric emptying. J Gastroenterol Hepatol 2003;18:41-6.
5. Liao CC, Lee CL, Chiang TC, et al. The 13C-urea breath test to detect Helicobacter pylori infection: a validated simple methodology with 50 mg 13C-urea. Aliment Pharmacol Ther 2002;16:787-92.
6. Eisenmann A, Amann A, Said M, Datta B, Ledochowski M. Implementation and interpretation of hydrogen breath test. J Breath Res 2 (2008) 046002 (9pp).
7. Schubert J, Miekisch W, Nöldge-Schomburg G. VOC breath markers in critically ill patients: potentials and limitations. In: Amann A, Smith D, editors. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. Singapore: World Scientific; 2005, p. 267-92.
8. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 2004;347:25-39.
9. Davies S, Spanel P, Smith D. A new 'online' method to measure increased exhaled isoprene in end-stage renal failure. Nephrol Dial Transplant 2001;16:836-9.
10. Davies S, Spanel P, Smith D. Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. Kidney Int 1997;52:223-8.
11. Davies SJ, Spanel P, Smith D. Quantitative analysis of metabolites on the breath of patients in renal failure. J Am Soc Nephrol 1996;7:A0352-A.
12. Perri F, Marras RM, Ricciardi R, Quitadamo M, Andriulli A. 13C-breath tests in hepatology (cytosolic liver function). Eur Rev Med Pharmacol Sci 2004;8:47-9.
13. Candelli M, Armuzzi A, Nista EC, Fini L, Gasbarrini G, Gasbarrini A. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 2004;19:243.
14. Phillips M, Altorki N, Austin JH, et al. Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark 2007;3:95-109.
15. Phillips M, Cataneo RN, Cummin AR, et al. Detection of lung cancer with volatile markers in the breath. Chest 2003;123:2115-23.
16. Phillips M, Cataneo RN, Ditkoff BA, et al. Volatile markers of breast cancer in the breath. Breast J 2003;9:184-91.
17. Wehinger A, Schmid A, Mechtcheriakov S, et al. Lung cancer detection by proton transfer reaction mass spectrometric analysis of human breath gas. Int J Mass Spec 2007;265:49-59.
18. Machado RF, Laskowski D, Deffenderfer O, et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 2005;171:1286-91.
19. Di Natale C, Macagnano A, Martinelli E, et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron 2003;18:1209-18.
20. Poli D, Carbognani P, Corradi M, et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res 2005;6:71.
21. Ligor M, Ligor T, Bajtarevic A, et al. Determination of volatile organic compounds appearing in exhaled breath of lung cancer patients by solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med 2009;47:550-60.
22. Brandacher G, Cakar F, Winkler C, et al. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation. Kidney Int 2007;71:60-7.
23. Bonatti H, Brandacher G, Boesmueller C, et al. Hemolytic uremic syndrome following Campath-1H induction. Transpl Int 2007;20:386-9.
24. Brandacher G, Winkler C, Schroecksnadel K, Margreiter R, Fuchs D. Antitumoral activity of interferon-γ involved in impaired immune function in cancer patients. Curr Drug Metab 2006;7:599-612.
25. Josting A, Rudolph C, Mapara M, et al. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol 2005;16:116-23.
26. Bunge M, Araghipour N, Mikoviny T, et al. On-line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry. Appl Environ Microbiol 2008;74:2179-86.
27. Syhre M, Scotter JM, Chambers ST. Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol 2008;46:209-15.
28. Syhre M, Chambers ST. The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2008;88:317-23.
29. Smith D, Wang TS, Sule-Suso J, Spanel P, El Haj A. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2003;17:845-50.
30. Chen X, Xu F, Wang Y, et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer 2007;110:835-44.
31. Filipiak W, Sponring A, Mikoviny T, et al. Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro. Cancer Cell Int 2008;8:17.
32. Sponring A, Filipiak W, Mikoviny T, et al. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anti-cancer Res 2009;29:419-26.
33. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
34. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976;17:62-70.
35. Giard DJ, Aaronson SA, Todaro GJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-23.
36. Hay RJ, Caputo CJ, Macy ML. ATCC Quality Control Methods for Cell Lines. 2nd Edition. Published by ATTC; 1992.
37. Kleinbaum D, Kupper L, Muller A, Nizam K. Applied Regression Analysis and Other Multivariable Methods. Pacific Grove (CA): Brooks/ Cole Publishing Company; 1998.
38. Phillips M, Altorki N, Austin JH, et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta 2008;393:76-84.
39. Acevedo CA, Sanchez EY, Reyes JG, Young ME. Volatile organic compounds produced by human skin cells. Biol Res 2007;40:347-55.